The Sabin Vaccine Institute PDP works on developing vaccines for the more than 700 million people suffering from hookworm in the world today. Established in 2000 with funding from the Bill & Melinda Gates Foundation, the Sabin PDP (originally the Human Hookworm Vaccine Initiative) is the first and only PDP in the world developing a vaccine for human hookworm infection.
The Sabin PDP is focused on the development of sustainable and cost-effective vaccines for preventing widespread neglected tropical diseases (NTDs), including hookworm, schistosomiasis, Chagas disease and leishmaniasis.
July 18, 2012
Last Friday, Sabin president Dr. Peter Hotez was a featured guest on Soledad O’Brien’s CNN morning show “Starting Point.” On the show, Dr. Hotez discussed the burden of neglected tropical diseases (NTDs) globally and closer to home in the United States.
June 12, 2012
At the Sabin Vaccine Institute, advocacy is big part of our business. We encourage politicians, philanthropists and the general public to expand immunization programs for vaccine-preventable diseases and increase treatment for over one billion people suffering from neglected tropical diseases.
But we’re also one of the few NGOs that is leading the research and development of vaccines to prevent diseases of poverty.
May 30, 2012 | Washington Post
May 25, 2012
SEATTLE -- “Today marks a huge victory in the fight to protect all children from vaccine-preventable diseases, no matter where they live."
May 25, 2012
The Sabin Vaccine Institute applauds the decision made today by the Sixty-fifth World Health Assembly to endorse the Global Vaccine Action Plan (GVAP). As a research and advocacy organization devoted to ensuring that life-saving vaccines reach the people that need them most, we commend this action plan, which lays the groundwork for the discovery, development and equitable delivery of vaccines.